Abstract
Campylobacter pylori has been implicated as a causative factor in acid-peptic disease. Lactobacillus acidophilus is known to inhibit the growth of pathogens in the human gastrointestinal tract. We recovered C. pylori from gastric antral biopsies of seven patients with acid-peptic disease; the isolates were then cultured in brucella broth. The effect of L. acidophilus (cultured in DeMan-Rogosa-Sharpe broth) on the growth of C. pylori was tested by a mixed culture technique. L. acidophilus inhibited the growth of all seven isolates of C. pylori in vitro. All these isolates were also inhibited by the L. acidophilus culture supernatant (brucella blood agar cup technique) obtained at or after 48 h of incubation. Inhibition of C. pylori growth was also observed with 1 and 3% lactic acid but not with 0.5 and 1% hydrogen peroxide, the L. acidophilus sonic extract, or a citrate-phosphate buffer (pH 4.0). We conclude that the inhibitory action of L. acidophilus on C. pylori is dependent on an extracellular secretory product, probably lactic acid. This inhibitory effect may be of therapeutic relevance in patients with C. pylori-positive acid-peptic disease.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Campylobacter-like organisms in the stomach of patients and healthy individuals. Lancet. 1984 Jun 16;1(8390):1348–1349. [PubMed] [Google Scholar]
- Collins E. B., Aramaki K. Production of Hydrogen peroxide by Lactobacillus acidophilus. J Dairy Sci. 1980 Mar;63(3):353–357. doi: 10.3168/jds.S0022-0302(80)82938-9. [DOI] [PubMed] [Google Scholar]
- GORDON D., MACRAE J., WHEATER D. M. A Lactobacillus preparation for use with antibiotics. Lancet. 1957 May 4;272(6975):899–901. doi: 10.1016/s0140-6736(57)91222-9. [DOI] [PubMed] [Google Scholar]
- Harvey S. M. Hippurate hydrolysis by Campylobacter fetus. J Clin Microbiol. 1980 Apr;11(4):435–437. doi: 10.1128/jcm.11.4.435-437.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hazell S. L., Hennessy W. B., Borody T. J., Carrick J., Ralston M., Brady L., Lee A. Campylobacter pyloridis gastritis II: Distribution of bacteria and associated inflammation in the gastroduodenal environment. Am J Gastroenterol. 1987 Apr;82(4):297–301. [PubMed] [Google Scholar]
- Kasper G. F. Natural sources and microbiological characteristics of Campylobacter pylori. Scand J Gastroenterol Suppl. 1988;142:14–15. [PubMed] [Google Scholar]
- MACBETH W. A., KASS E. H., MCDERMOTT W. V., Jr TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS. Lancet. 1965 Feb 20;1(7382):399–403. doi: 10.1016/s0140-6736(65)90002-4. [DOI] [PubMed] [Google Scholar]
- Marshall B. J., Goodwin C. S., Warren J. R., Murray R., Blincow E. D., Blackbourn S. J., Phillips M., Waters T. E., Sanderson C. R. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988 Dec 24;2(8626-8627):1437–1442. doi: 10.1016/s0140-6736(88)90929-4. [DOI] [PubMed] [Google Scholar]
- Marshall B. J., Warren J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984 Jun 16;1(8390):1311–1315. doi: 10.1016/s0140-6736(84)91816-6. [DOI] [PubMed] [Google Scholar]
- Shahani K. M., Ayebo A. D. Role of dietary lactobacilli in gastrointestinal microecology. Am J Clin Nutr. 1980 Nov;33(11 Suppl):2448–2457. doi: 10.1093/ajcn/33.11.2448. [DOI] [PubMed] [Google Scholar]
- Shore E. G., Dean A. G., Holik K. J., Davis B. R. Enterotoxin-producing Escherichia coli and diarrheal disease in adult travelers: a prospective study. J Infect Dis. 1974 May;129(5):577–582. doi: 10.1093/infdis/129.5.577. [DOI] [PubMed] [Google Scholar]